Insider Trading April 15, 2026 09:22 PM

Ouster CTO Disposes of $1.39M in Stock as Company Posts Strong Quarter

Mark Frichtl sold 60,000 shares while exercising options; Ouster's Q4 2025 results and analyst moves accompany the filings

By Avery Klein OUST
Ouster CTO Disposes of $1.39M in Stock as Company Posts Strong Quarter
OUST

Ouster Chief Technology Officer Mark Frichtl sold 60,000 shares of common stock across April 14 and 15, 2026, for about $1.39 million, according to a Form 4 filing. The transactions were carried out under a pre-arranged Rule 10b5-1 plan and coincided with robust stock performance and solid fourth-quarter results reported by the company.

Key Points

  • Ouster CTO Mark Frichtl sold 60,000 shares across April 14-15, 2026, for approximately $1.39 million at prices ranging from $22.7562 to $24.00 - transactions executed under a Rule 10b5-1 plan.
  • Frichtl exercised 60,000 options at $2.13 per share for a total exercise cost of $127,800; the exercise-and-sell generated roughly $1.26 million before taxes.
  • Ouster reported strong Q4 2025 results - about $62 million in revenue, roughly 60% GAAP gross margin, and EPS of $0.06 - prompting analyst support from Cantor Fitzgerald and an increased price target from Oppenheimer.

Ouster, Inc. (NASDAQ: OUST) Chief Technology Officer Mark Frichtl reported the sale of 60,000 shares of common stock on April 14 and April 15, 2026, totaling roughly $1.39 million. The share disposals were executed at prices between $22.7562 and $24.00, according to a Form 4 filing submitted to the Securities and Exchange Commission.

The stock sales were split into two tranches: 40,000 shares sold on April 14 and a subsequent 20,000 shares sold on April 15. The filing states these trades were completed under a Rule 10b5-1 trading plan that was put in place on December 15, 2025, and that some of the sales were undertaken for tax planning purposes.

On the same dates as the share sales, Frichtl also exercised stock options to acquire 60,000 shares of Ouster common stock at an exercise price of $2.13 per share, representing a combined exercise cost of $127,800. The filing indicates the options were fully vested and exercisable at the time of exercise. The exercise-and-sell sequence produced proceeds of approximately $1.26 million before tax withholdings.

The timing of the transactions coincided with a strong trading week for Ouster shares. The stock advanced about 22% over the prior seven days and has delivered a cumulative return of 254% over the past year. As of the latest quote referenced in the filing, Ouster shares were trading at $24.43, which is close to InvestingPro's Fair Value estimate of $24.88.

InvestingPro subscribers are noted to have access to additional ProTips on Ouster, including commentary on the company's financial health and volatility patterns.


In other filings and company disclosures, Ouster reported robust fourth-quarter results for fiscal 2025. Revenue for the quarter reached approximately $62 million, materially above the Visible Alpha consensus estimate of $41.2 million. The company also posted a GAAP gross margin near 60% for the quarter, outpacing expectations cited by Cantor Fitzgerald and Visible Alpha.

Ouster reported earnings per share of $0.06 for the quarter, compared with an expected loss per share of $0.14. Following these results, Cantor Fitzgerald reiterated an Overweight rating on Ouster. Separately, Oppenheimer raised its price target on the company to $40, citing progress in software and positive guidance for the first quarter of fiscal 2026.

The company also announced an internal leadership change, promoting Cyrille Jacquemet to the role of Chief Revenue Officer. The appointment was highlighted in the company notices accompanying the earnings disclosures.


These developments - the insider transaction, option exercise-and-sell, strong quarterly performance and analyst activity - are presented in the filings and announcements disclosed by the company and regulators. The Form 4 filing documents the mechanics and timing of Frichtl's trades, while the earnings report and analyst actions provide context on Ouster's recent operational and market performance.

Readers should note that the Form 4 filing records the disposition and the option exercise details, and that the company-reported financial results show revenue, margin and EPS results that exceeded the cited consensus and analyst expectations for the quarter.

Risks

  • Recent insider selling occurred, albeit under a pre-arranged Rule 10b5-1 plan and for tax planning purposes, which may be interpreted variably by market participants - this relates to investor perception in the equity markets.
  • The stock has exhibited pronounced short-term moves, including a 22% gain in the prior seven days and a 254% return over the past year, indicating significant volatility that can affect trading and valuation in equity markets.
  • The current share price of $24.43 sits close to InvestingPro's Fair Value estimate of $24.88, suggesting limited valuation gap versus the referenced fair value assessment.

More from Insider Trading

Travere Legal Chief Sells $2.13M in Stock After Option Exercises and PSU Vesting Apr 15, 2026 Travere CFO Sells $348,974 in Stock Following PSU Vesting After FDA Approval Apr 15, 2026 Travere Commercial Chief Disposes $302,516 of Stock After Vesting Event and FDA Nod for Filspari Apr 15, 2026 Travere CEO Sells $2.63M in TVTX Shares as FILSPARI Gains FDA Approval Apr 15, 2026 Travere Therapeutics CMO Disposes $345k of TVTX Stock After PSU Vesting Apr 15, 2026